meetings

Transcript, Meeting 11, Session 3

SESSION 3: MCM USE AND RESEARCH IN A POST-EVENT SCENARIO

DR. WAGNER:  So, let’s get started. 

We are shifting now from, um, uh, pre-event discussions to post event.  MCM use, medical countermeasures use and research and post-event scenarios, and we will again, the format, we’ll ask each of you to make your presentations, and then open it for questions.

Date

Mon, 11/05/2012

Transcript, Meeting 11, Session 7

SESSION 7: MEMBER DISCUSSION

DR. GUTMANN:  Welcome back everybody.  We have until 11:45, right?  Great.  So, we'll take an hour and then wrap up. 

Date

Tue, 11/06/2012

Transcript, Meeting 11, Session 4

SESSION 4: ROUNDTABLE DISCUSSION

DR. WAGNER: We appreciate you all hanging around for a roundtable.  We have found these to be, uh, uh, very helpful, uh, although they tend to be extremely wide ranging and, uh, and I’m concerned that there isn’t – we try – in order to keep them from just going, spinning immediately out of control, we try to, uh, pose a framing question.  It’s very hard to pose a framing question for this one but, maybe we can start with something like this.

Date

Mon, 11/05/2012

Transcript, Meeting 11, Session 2

SESSION 2: MEDICAL COUNTERMEASURE (MCM) DISTRIBUTION

DR. WAGNER:  Let me invite our next session, experts forward, Bruce Lockwood, Dr. Benjamin. 

Date

Mon, 11/05/2012

Transcript, Meeting 11, Session 1

DR. WAGNER:  I believe we are assembled. I’m Jim Wagner.  It’s my privilege to be serving Emory University as its president.  I also am privileged to be the Vice Chair of this President’s Commission on the Study of Bioethical Issues.  Our chairman, Amy Gutmann, has asked me to convey, uh, regrets, at least for this first day of our meetings.  She had something come up on Saturday, uh which obligates her today and requires her attention today, but she’ll be flying in I believe this evening to be with us tomorrow.

Date

Mon, 11/05/2012

Transcript, Meeting 10, Session 2

SESSION 2: PROTECTION OF PRIVATE AND PUBLIC GENOMIC DATABASES

DR. WAGNER:  Our next session is on protection of private and public genomic databases.  And if Dr. Chahine and -- Drs. Chahine and Rodriguez would come forward.  Wonderful.

We'll be hearing first from Dr. Ken Chahine.  He is the senior vice president of Ancestry.com, well known online resource for family history and general manager for Ancestry DNA where he leads the development and commercialization of population genetics at the website which is the same name, AncestryDNA.com. 

Date

Wed, 08/01/2012

Pages

Subscribe to RSS - meetings